Retraction: Sung et al. Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate. Vaccines 2022, 10, 2

Johnny Chun-Chau Sung; Ying Liu; Kam-Chau Wu; Man-Chung Choi; Chloe Ho-Yi Ma; Jayman Lin; Emily Isabel Cheng He; David Yiu-Ming Leung; Eric Tung-Po Sze; Yusuf Khwaja Hamied; Dominic Man-Kit Lam; Keith Wai-Yeung Kwong

doi:10.3390/vaccines10111852

Retraction: Sung et al. Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate. Vaccines 2022, 10, 2

Vaccines (Basel). 2022 Nov 1;10(11):1852. doi: 10.3390/vaccines10111852.

Authors

Johnny Chun-Chau Sung^{1

2

3

4}, Ying Liu^{1

3}, Kam-Chau Wu¹, Man-Chung Choi¹, Chloe Ho-Yi Ma¹, Jayman Lin^{1

4}, Emily Isabel Cheng He¹, David Yiu-Ming Leung^{5

6}, Eric Tung-Po Sze⁷, Yusuf Khwaja Hamied⁸, Dominic Man-Kit Lam^{4

9}, Keith Wai-Yeung Kwong^{1

2

3

8}

Affiliations

¹ Research Department, DreamTec Cytokines Limited, Hong Kong, China.
² Oristry BioTech (HK) Limited, Hong Kong, China.
³ Meserna Therapeutic (HK) Limited, Hong Kong, China.
⁴ L&L Immunotherapy Company Limited, Hong Kong, China.
⁵ Zentrogene Bioscience Laboratory Limited, Hong Kong, China.
⁶ Health Plus Laboratory Limited, Hong Kong, China.
⁷ School of Science and Technology, Hong Kong Metropolitan University, Hong Kong, China.
⁸ Cipla Limited, Mumbai 400013, India.
⁹ Torsten Wiesel International Research Institute, Sichuan University, Chengdu 610017, China.

Abstract

The journal retracts the article "Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate"[...].

Publication types

Retraction of Publication